Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

align technology inc. - ALGN

ALGN

Close Chg Chg %
223.87 4.34 1.94%

Closed Market

228.21

+4.34 (1.94%)

Volume: 475.02K

Last Updated:

Nov 21, 2024, 4:00 PM EDT

Trade Now

Company Overview: align technology inc. - ALGN

ALGN Key Data

Open

$225.00

 Day Range

224.53 - 229.22

52 Week Range

196.09 - 335.20

 Market Cap

$16.71B

Shares Outstanding

74.65M

 Public Float

69.71M

Beta

1.65

 Rev. Per Employee

N/A

P/E Ratio

38.17

 EPS

$5.87

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

913.21K

  

ALGN Performance

1 Week
 
 2.02%
 
1 Month
 
 4.06%
 
3 Months
 
 -2.46%
 
1 Year
 
 3.98%
 
5 Years
 
 -16.83%
 

ALGN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 16
Full Ratings ➔

About align technology inc. - ALGN

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

ALGN At a Glance

Align Technology, Inc.
410 North Scottsdale Road
Tempe, Arizona 85288
Phone 1-602-742-2000 Revenue 3.86B
Industry Medical Specialties Net Income 445.05M
Sector Health Technology 2023 Sales Growth 3.417%
Fiscal Year-end 12 / 2024 Employees 21,610
View SEC Filings

ALGN Valuation

P/E Current 38.169
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 47.14
Price to Sales Ratio 5.432
Price to Book Ratio 5.666
Price to Cash Flow Ratio 26.699
Enterprise Value to EBITDA 25.197
Enterprise Value to Sales 5.213
Total Debt to Enterprise Value 0.006

ALGN Efficiency

Revenue/Employee 178,725.59
Income Per Employee 20,594.771
Receivables Turnover 3.688
Total Asset Turnover 0.642

ALGN Liquidity

Current Ratio 1.184
Quick Ratio 1.04
Cash Ratio 0.471

ALGN Profitability

Gross Margin 70.557
Operating Margin 17.002
Pretax Margin 16.602
Net Margin 11.523
Return on Assets 7.398
Return on Equity 12.308
Return on Total Capital 11.846
Return on Invested Capital 11.981

ALGN Capital Structure

Total Debt to Total Equity 3.488
Total Debt to Total Capital 3.37
Total Debt to Total Assets 2.081
Long-Term Debt to Equity 2.671
Long-Term Debt to Total Capital 2.581
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Align Technology Inc. - ALGN

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
2.47B 3.95B 3.73B 3.86B
Sales Growth
+2.71% +59.90% -5.51% +3.42%
Cost of Goods Sold (COGS) incl D&A
696.13M 999.02M 1.08B 1.14B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
115.97M 135.51M 156.32M 142.40M
Depreciation
102.57M 118.91M 140.32M 126.00M
Amortization of Intangibles
13.40M 16.60M 16.00M 16.40M
COGS Growth
+7.02% +43.51% +8.55% +4.86%
Gross Income
1.78B 2.95B 2.65B 2.73B
Gross Income Growth
+1.11% +66.32% -10.27% +2.83%
Gross Profit Margin
+71.84% +74.72% +70.96% +70.56%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.38B 1.96B 1.98B 2.05B
Research & Development
175.31M 250.31M 305.26M 346.83M
Other SG&A
1.20B 1.71B 1.67B 1.70B
SGA Growth
+11.93% +42.36% +1.06% +3.56%
Other Operating Expense
12.58M 18.21M 16.43M 18.25M
Unusual Expense
16.09M (43.40M) 11.45M 13.32M
EBIT after Unusual Expense
371.08M 1.02B 642.60M 643.34M
Non Operating Income/Expense
7.87M (7.38M) (43.54M) (2.13M)
Non-Operating Interest Income
3.13M 3.10M 5.37M 17.26M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
378.95M 1.01B 599.06M 641.20M
Pretax Income Growth
-32.65% +167.17% -40.83% +7.04%
Pretax Margin
+15.33% +25.61% +16.04% +16.60%
Income Tax
(1.40B) 240.40M 237.48M 196.15M
Income Tax - Current - Domestic
64.15M 185.75M 222.67M 162.87M
Income Tax - Current - Foreign
29.40M 42.68M 56.54M 51.31M
Income Tax - Deferred - Domestic
(13.87M) (31.46M) (67.84M) (19.96M)
Income Tax - Deferred - Foreign
(1.48B) 43.43M 26.12M 1.94M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.78B 772.02M 361.57M 445.05M
Minority Interest Expense
- - - -
-
Net Income
1.78B 772.02M 361.57M 445.05M
Net Income Growth
+301.08% -56.53% -53.17% +23.09%
Net Margin Growth
+71.84% +19.53% +9.68% +11.52%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.78B 772.02M 361.57M 445.05M
Preferred Dividends
- - - -
-
Net Income Available to Common
1.78B 772.02M 361.57M 445.05M
EPS (Basic)
22.5481 9.7827 4.6243 5.8233
EPS (Basic) Growth
+304.46% -56.61% -52.73% +25.93%
Basic Shares Outstanding
78.76M 78.92M 78.19M 76.43M
EPS (Diluted)
22.4143 9.6902 4.6107 5.8125
EPS (Diluted) Growth
+305.48% -56.77% -52.42% +26.07%
Diluted Shares Outstanding
79.23M 79.67M 78.42M 76.57M
EBITDA
503.14M 1.11B 810.37M 799.05M
EBITDA Growth
-18.57% +120.99% -27.12% -1.40%
EBITDA Margin
+20.35% +28.13% +21.70% +20.69%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 261.00
Number of Ratings 16 Current Quarters Estimate 2.456
FY Report Date 12 / 2024 Current Year's Estimate 9.322
Last Quarter’s Earnings 2.35 Median PE on CY Estimate N/A
Year Ago Earnings 8.61 Next Fiscal Year Estimate 10.252
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 10 14 14
Mean Estimate 2.46 2.30 9.32 10.25
High Estimates 2.53 2.52 9.46 10.55
Low Estimate 2.37 2.11 9.02 9.92
Coefficient of Variance 1.84 5.20 1.14 2.07

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 7
OVERWEIGHT 2 2 2
HOLD 4 5 6
UNDERWEIGHT 1 1 1
SELL 1 1 0
MEAN Overweight Overweight Overweight

Insider Actions for Align Technology Inc. - ALGN

Date Name Shares Transaction Value
Aug 20, 2024 C. Raymond Larkin Director 23,597 Bona fide gift 0.00
Aug 20, 2024 C. Raymond Larkin Director 28,247 Open market or private purchase of non-derivative security Non-derivative transaction at $235.33 per share 6,647,366.51
May 22, 2024 George J. Morrow Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Susan E. Siegel Director 7,830 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Andrea L. Saia Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Andrea L. Saia Director 14,425 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Joseph S. Lacob Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Joseph S. Lacob Director 133,023 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Susan E. Siegel Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Anne M. Myong Director 6,937 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Kevin J. Dallas Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Anne M. Myong Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 Kevin J. Dallas Director 13,275 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 22, 2024 George J. Morrow Director 2,143 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 1, 2024 Joseph S. Lacob Director 132,794 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $303.59 per share 40,314,930.46
Mar 1, 2024 Joseph S. Lacob Director 131,994 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $304.76 per share 40,226,491.44
Feb 23, 2024 Joseph M. Hogan PRESIDENT AND CEO; Director 31,707 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 23, 2024 Joseph M. Hogan PRESIDENT AND CEO; Director 11,017 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 23, 2024 Joseph M. Hogan PRESIDENT AND CEO; Director 1,412 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 23, 2024 Joseph M. Hogan PRESIDENT AND CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Align Technology Inc. in the News